Category Archives: Research and Development

PrEP: Risk of resistance to antiretroviral drugs used to prevent infection is lower than thought, study finds

By on .

Highest risk of resistance found in those starting drugs with undiagnosed infection, pointing to importance of screening The landmark study that found preventive use of antiretroviral medicine by a person who is not infected with HIV can lower the risk of acquiring the virus from his or her infected partner has yielded data showing that […]

AVAC: HIV vaccine, microbicides, PrEP trial results say reality must guide research

By on .

For all the graphics illustrating results of HIV prevention trials in recent years, the Venn diagram on the cover of Research & Reality, the report released by AVAC today, may be the one that depicts the sum of their findings. Which is really saying something, when one considers the up-and-down nature of prevention research results […]

Report shows U.S. HIV research investment, progress; projects lasting impact from cuts

By on .

With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report released at the International AIDS Society conference in Kuala Lumpur this […]

With study of injecting drug users, preventive HIV medicine demonstrates protective value to all at high risk

By on .

CDC releases updated Guidance for Pre-Exposure Prophylaxis for the Prevention of HIV Infection: PrEP for Injecting Drug Users, while questions on real-world impact remain With a five-year study in Bangkok showing that daily doses of antiretroviral medicine reduced risks of HIV infection among people who inject drugs by at least half, and more with the […]

HIV prevention: on the verge of transformation

By on .

A look at the recent AIDS Vaccine 2012 Conference shows range of prevention developments The following is a guest post from Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI) and William Snow, director of the Global HIV Vaccine Enterprise. More than 1,000 HIV researchers and other professionals involved in HIV prevention […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]

AIDS Vaccine 2012 will highlight scope of promising prevention advances

By on .

With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers […]